{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:12:44Z","timestamp":1789135964744,"version":"build-2803163510"},"reference-count":20,"publisher":"Scientific Scholar","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jor.2019.06.030","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T01:39:41Z","timestamp":1561945181000},"page":"17-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Altering the natural history of rheumatoid arthritis: The role of immunotherapy and biologics in orthopaedic care"],"prefix":"10.25259","volume":"17","author":[{"given":"Steven J.","family":"Girdler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"10.1016\/j.jor.2019.06.030_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11926-013-0365-8","article-title":"Changing incidence of orthopedic surgery in rheumatic disease: contributing factors","volume":"15","author":"Bernstein","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jor.2019.06.030_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","author":"Deane","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jor.2019.06.030_bib3","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jor.2019.06.030_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/acr.22783","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jor.2019.06.030_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.10697","article-title":"Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial","volume":"48","author":"Weinblatt","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jor.2019.06.030_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000957.pub2","article-title":"Methotrexate for treating rheumatoid arthritis","author":"Lopez-Olivo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jor.2019.06.030_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030275","article-title":"Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis","author":"Aaltonen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jor.2019.06.030_bib8","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/rheumatology\/kem072","article-title":"The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons","volume":"46","author":"Nixon","year":"2007","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.jor.2019.06.030_bib9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(13)60250-0","article-title":"Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial","volume":"381","author":"Gabay","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.jor.2019.06.030_bib10","series-title":"B Cell Trophic Factors and B Cell Antagonism in Autoimmune Disease","first-page":"140","article-title":"The biology of CD20 and its potential as a target for mAb therapy","author":"Cragg","year":"2004"},{"key":"10.1016\/j.jor.2019.06.030_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007356.pub2","article-title":"Rituximab for rheumatoid arthritis","author":"Lopez-Olivo","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jor.2019.06.030_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/art.37711","article-title":"Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study","volume":"65","author":"Weinblatt","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jor.2019.06.030_bib13","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1056\/NEJMoa1310476","article-title":"Tofacitinib versus methotrexate in rheumatoid arthritis","volume":"370","author":"Lee","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jor.2019.06.030_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1874325001509010078","article-title":"Surgical management of the forefoot in patients with rheumatoid arthritis -a review article","volume":"9","author":"Nash","year":"2015","journal-title":"Open Orthop J"},{"key":"10.1016\/j.jor.2019.06.030_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2106\/00004623-200108000-00013","article-title":"Posterior cruciate ligament-retaining total knee arthroplasty in patients with rheumatoid arthritis","volume":"83","author":"Archibeck","year":"2001","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jor.2019.06.030_bib16","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3899\/jrheum.131018","article-title":"Recent trends in orthopedic surgery aiming to improve quality of life for those with rheumatoid arthritis: data from a large observational cohort","volume":"41","author":"Momohara","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jor.2019.06.030_bib17","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3899\/jrheum.130118","article-title":"Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy","volume":"40","author":"Leon","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jor.2019.06.030_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/s10165-009-0262-1","article-title":"Impact of biologics on the prevalence of orthopedic surgery in the national database of rheumatic diseases in Japan","volume":"20","author":"Yasui","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jor.2019.06.030_bib19","first-page":"53","article-title":"The implications of biologic therapy for elective foot and ankle surgery in patients with rheumatoid arthritis","volume":"30","author":"Diaper","year":"2017","journal-title":"Foot (Edinburgh, Scotland)"},{"issue":"2017","key":"10.1016\/j.jor.2019.06.030_bib20","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/acr.23274","article-title":"American College of Rheumatology\/American association of hip and knee surgeons guideline for the perioperative management of ANturheumatic medication in patients with rheumatic diseased undergoinng elective total hip or total knee arthroplasty","volume":"68","author":"Goodman","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"}],"updated-by":[{"DOI":"10.1016\/j.jor.2020.12.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"container-title":["Journal of Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972978X19300467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0972978X19300467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:03:17Z","timestamp":1789135397000},"score":1,"resource":{"primary":{"URL":"https:\/\/jortho.org\/altering-the-natural-history-of-rheumatoid-arthritis-the-role-of-immunotherapy-and-biologics-in-orthopaedic-care\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":20,"alternative-id":["S0972978X19300467"],"URL":"https:\/\/doi.org\/10.1016\/j.jor.2019.06.030","relation":{},"ISSN":["0972-978X"],"issn-type":[{"value":"0972-978X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altering the natural history of rheumatoid arthritis: The role of immunotherapy and biologics in orthopaedic care","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jor.2019.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}